Skip to main content

Advisors predict there is going to be a big overlap between the alcohol and tobacco industries and legal cannabis. For instance, U.S. beer and wine giant Constellation Brands Inc. last fall bought a near 10-per-cent stake in Canadian marijuana producer Canopy Growth Corp. to collaborate on cannabis-infused drinks.

COSTAS BALTAS/REUTERS

When it comes to investing, vice can sometimes be nice.

Owning so-called sin stocks, such as companies involved with tobacco, alcohol, casinos, arms and cannabis, potentially can be rewarding. While more exchange-traded funds (ETFs) offer exposure to this naughty niche, investors need to check under their hood and assess their risk tolerance before jumping onboard.

Alcohol and tobacco stocks are particularly compelling because "they are recession-resistant – if not recession proof," says Dan Ahrens, chief operating officer of U.S.-based AdvisorShares Investments and author of Investing in Vice. "They have been steady performers for decades and are very good dividend payers. … Tobacco also has the largest profit margin of any consumer product."

Story continues below advertisement

Mr. Ahrens's background in this niche stems from a stint as the first of several managers to run the USA Mutuals Vice Investor mutual fund launched in 2002. Since inception, this fund, which invests in the alcohol, tobacco, gaming and defence industries, has outpaced the S&P 500 Index, including dividends.

Now, he is the portfolio manager for the relatively new actively managed U.S.-listed AdvisorShares Vice ETF, which invests only in tobacco, alcohol and cannabis-related names. "There is going to be a big overlap between the alcohol and tobacco industries and legal cannabis," he predicts.

For instance, U.S. beer and wine giant Constellation Brands Inc. last fall bought a near 10-per-cent stake in Canadian marijuana producer Canopy Growth Corp. to collaborate on cannabis-infused drinks.

Because marijuana is not legal federally in the United States, his ETF invests only in ancillary companies such as AbbVie Inc., which markets a cannabis-based drug, and Scotts Miracle-Gro Co., whose hydroponic business allows cannabis and other plants to grow indoors.

When investing in U.S.-listed ETFs holding cannabis stocks, investors need to "look under the hood" for regulatory risk, Mr. Ahrens warns. Some U.S. states have legalized marijuana, but "it is federally not legal to invest directly in marijuana companies," he said. "Domestic [U.S.] funds could be forced to divest from their illegal investments. … It is different in Canada, of course."

ETF Managers Group LLC, which markets the Spirited Funds/ETFMG Whiskey and Spirits ETF, launched the ETFMG Alternative Harvest ETF in December. This is the first U.S.-listed marijuana fund and was converted from an existing real estate ETF.

Because this fund tracks some Canadian cannabis companies, U.S. Bancorp is reviewing whether to remain as the ETF's custodian to avoid running afoul of the law. If it walks away, and a replacement is not found, this ETF may be liquidated.

Story continues below advertisement

More Canadian-listed cannabis ETFs, meanwhile, are rolling out to get ready for legalization of recreational marijuana by summer.

Horizons Marijuana Life Sciences ETF was launched last year, while its sister, Horizons Emerging Marijuana Growers ETF, is set to list tomorrow. Unlike their index-oriented peers, Redwood Marijuana Opportunities ETF and Evolve Marijuana ETF use an actively managed strategy for their cannabis funds.

While the marijuana niche has been a hot play recently, National Bank Financial ETF analyst Daniel Straus cautions investors to approach the more volatile cannabis equities differently from their established sin-stocks peers.

The alcohol and tobacco industries have been very profitable, and their stock valuations are typically lower than the broader market possibly because some investors avoid them, he said. "They are … a source of value."

But cannabis stocks are an outlier because there is so much speculative interest in them, he said. "There is a lot of uncertainty and a lot of very high valuations. Some of these companies have billion-dollar market-caps, zero revenue and negative earnings. … Any future growth may be priced in [the stocks]."

Cannabis ETFs are suited to aggressive, growth-oriented investors with a time horizon of 10 to 20 years, and who could sustain a total loss, he suggested. While these ETFs are risky, there is also possibility for "enormous future returns."

Story continues below advertisement

For instance, the Horizons Marijuana Life Sciences ETF, which listed at $10 a unit last April, more than doubled to the $24-per-unit range last month. It has since pulled back to $18 amid the market downturn.

Alex Bryan, an ETF analyst at Chicago-based Morningstar Inc., suggested that it's better to approach sin-stock ETFs as shorter-term, tactical plays. "There are times when you may want this exposure, and times when you may not," he said.

The gaming sector tends to be "a little more cyclical," Mr. Bryan noted. "A lot of people treat casino visits as an entertainment or discretionary expense, so [this sector] tends to do better when people have more money to spend."

While alcohol and tobacco are more defensive sectors, "you still have a bit of risk if, let's say, people continue to reduce their tobacco use," he suggested. Cannabis is more of an emerging-growth story and "basically a bet on relaxing restrictions on the use of cannabis in the United States and other markets," he said.

"But there is still a lot of uncertainty about how the regulations will shake out, especially in the United States, in terms of enforcement," Mr. Bryan echoed. "There are certainty a lot of risks associated with that particular trade."

Ways to add vice to a portfolio

Story continues below advertisement

– AdvisorShares Vice ETF (ACT) invests in U.S. alcohol, tobacco and cannabis-related stocks. Holdings include Constellation Brands Inc., Philip Morris International Inc. and AbbVie Inc. Its fee is 0.75 per cent.

– VanEck Vectors Gaming ETF (BJK) focuses on casinos, casino hotels, sports betting and gaming companies. Holdings include Galaxy Entertainment Group Ltd. and Las Vegas Sands Corp. The fund charges a 0.67-per-cent fee.

– Horizons Marijuana Life Sciences ETF (HMMJ) invests in North American cannabis and cannabis-related firms. Top names include Aurora Cannabis Inc. and Canopy Growth Corp. The ETF's fee is expected to be just over 0.75 per cent.

Redwood Marijuana Opportunities ETF (MJJ), which uses an actively managed strategy, invests in cannabis or cannabis-related firms. It is also sold as a mutual fund, and recently had 30 per cent in cash. The ETF's fee is expected to be just over 0.75 per cent.

ETFMG Alternative Harvest ETF (MJ) owns North American cannabis and cannabis-related firms. Holdings include Canada-based Chronos Group Inc., Aurora Cannabis and Canopy Growth. The fee is 0.75 per cent.

Evolve Marijuana ETF (SEED) is an actively managed portfolio which owns companies involved in the marijuana industry. Aurora Cannabis Inc. and Cronos Group Inc. are among the top names. Canadian stocks make up 94 per cent of the fund. The ETF charges a 1-per-cent fee.

Story continues below advertisement

Spirited Funds/ETFMG Whiskey & Spirits ETF (WSKY) invests in companies producing and selling whisky and spirits. Top names include Diageo PLC and Pernod Ricard SA, and Distell Group Ltd. The fund charges a 0.60-per-cent fee.

Report an error Editorial code of conduct
Tickers mentioned in this story
Unchecking box will stop auto data updates
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.
Comments are closed

We have closed comments on this story for legal reasons or for abuse. For more information on our commenting policies and how our community-based moderation works, please read our Community Guidelines and our Terms and Conditions.

Cannabis pro newsletter
To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies